Promise Bio
AI-powered epiproteomic analysis platform for mass spectrometry data.
About
Promise Bio utilizes a cloud-based AI platform to perform unbiased, broad-range epiproteomic analyses on standard mass spectrometry data. Their technology focuses on studying post-translational modifications (PTMs) that regulate protein activity, offering deeper insights into biological processes. Teams look it up for Life Sciences, Biotech, Proteomics.
Frequently asked
What does Promise Bio do?
Promise Bio is a Life Sciences company that offers Software. Teams look it up for Biotech, Proteomics, HealthTech. It is based in San Francisco, United States and was founded in 2022. Public records show about 14 people and $10M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Promise Bio raised?
Promise Bio has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Promise Bio headquartered?
Promise Bio is headquartered in San Francisco, United States.
When was Promise Bio founded?
Promise Bio was founded in 2022.
What industry does Promise Bio operate in?
Promise Bio operates in Life Sciences, Biotech, Proteomics, HealthTech, Genomics.
How many employees does Promise Bio have?
Promise Bio has approximately 14 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.